124 related articles for article (PubMed ID: 3934994)
1. Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma.
Alvarado CS; Faraj BA; Kim TH; Camp VM; Bain RP; Ragab AH
Am J Pediatr Hematol Oncol; 1985; 7(3):221-7. PubMed ID: 3934994
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
Eldrup E; Clausen N; Scherling B; Schmiegelow K
Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
[TBL] [Abstract][Full Text] [Related]
3. Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma.
Johnson GA; Baker CA; Smith RT
Life Sci; 1980 May; 26(19):1591-8. PubMed ID: 6770210
[No Abstract] [Full Text] [Related]
4. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma.
Boomsma F; Ausema L; Hakvoort-Cammel FG; Oosterom R; Man in't Veld AJ; Krenning EP; Hahlen K; Schalekamp MA
Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1045-52. PubMed ID: 2503383
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of catecholamine biosynthesis by carbidopa and metyrosine in neuroblastoma.
Anton AH; Crumrine RS; Stern RC; Izant RJ
Pediatr Pharmacol (New York); 1983; 3(2):107-17. PubMed ID: 6425794
[TBL] [Abstract][Full Text] [Related]
6. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
7. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma.
Ikeda H; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
Hypertens Res; 1995 Jun; 18 Suppl 1():S209-10. PubMed ID: 8529065
[TBL] [Abstract][Full Text] [Related]
8. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
[TBL] [Abstract][Full Text] [Related]
9. Catecholamine metabolism in neuroblastoma.
LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
[TBL] [Abstract][Full Text] [Related]
10. Plasma catecholamines in the chronically cannulated sheep fetus: predominance of L-dihydroxyphenylalanine.
Ben-Jonathan N; Arbogast LA; Rhoades TA; Schillo KK; Pau KY; Jackson GL
Endocrinology; 1983 Jul; 113(1):216-21. PubMed ID: 6407822
[TBL] [Abstract][Full Text] [Related]
11. Abnormal 3,4-dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis.
Schöni MH; Türler K; Käser H; Kraemer R
Eur J Clin Invest; 1990 Jun; 20(3):272-8. PubMed ID: 2114988
[TBL] [Abstract][Full Text] [Related]
12. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
[TBL] [Abstract][Full Text] [Related]
13. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
[TBL] [Abstract][Full Text] [Related]
14. [Serum catecholamine concentrations and hemodynamics during operations on 23 children with neuroblastoma].
Fujimura H; Kitamura S; Kawahara R; Takada Y; Ohnishi Y; Maeda L
Masui; 1992 Jun; 41(6):919-24. PubMed ID: 1613951
[TBL] [Abstract][Full Text] [Related]
15. DOPA metabolism in neuroblastoma.
Helson L; Johnson GA; Smith R
Med Pediatr Oncol; 1980; 8(4):317-22. PubMed ID: 6779102
[TBL] [Abstract][Full Text] [Related]
16. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
Kuchel O; Buu NT; Edwards DJ
J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
[TBL] [Abstract][Full Text] [Related]
17. Total plasma dopamine/norepinephrine ratio in catecholamine-secreting tumors. Its relation to hypertension.
Puyo A; Levin G; Armando I; Barontini M
Hypertension; 1988 Feb; 11(2 Pt 2):I202-6. PubMed ID: 3346058
[TBL] [Abstract][Full Text] [Related]
18. Sources and significance of plasma levels of catechols and their metabolites in humans.
Goldstein DS; Eisenhofer G; Kopin IJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306
[TBL] [Abstract][Full Text] [Related]
19. Effect of in vitro hemolysis on assay of plasma catecholamines and DOPA.
Smith RT
Clin Chem; 1980 Aug; 26(9):1354-6. PubMed ID: 6772343
[TBL] [Abstract][Full Text] [Related]
20. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
